Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia (AMIKINHAL)
Double-blinded Multicenter Randomized Controlled Trial Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia
Sponsor: University Hospital, Tours
This PHASE3 trial investigates Pneumonia, Ventilator-Associated and is currently completed. University Hospital, Tours leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Jan 2026 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jul 2024 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Mar 2021 — Dec 2022 [monthly]
Recruiting PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Mar 2020 — Dec 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Mar 2020 [monthly]
Recruiting PHASE3
-
Jan 2018 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Jan 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Tours
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Angers, France , Angoulême, France , Argenteuil, France , Colombes, France , Dijon, France , La Roche-sur-Yon, France , Le Mans, France , Lyon, France , Orléans, France , Paris, France and 5 more locations